Search results
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe re-agents are pivotal in manufacturing viral vectors, a key component in the development of cell...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 1 day agoMirus furthers Merck KGaA’s “ambition to provide a fully integrated and comprehensive solution for viral vector manufacturing,” the company said...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoKeytruda has played an instrumental role in driving Merck’s steady revenue growth in the past few...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 1 hour ago(For example, it helps drug companies manage their clinical trials.) Its myriad customers include...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 15 hours agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
I Couldn’t Escape Poison Oak. So I Started Eating It.
The Wall Street Journal· 6 days agoBy that decade, a raft of poison-ivy-extract pills and shots could be purchased from companies...
Madison-based life science company Mirus Bio to be acquired for $600 million
Small Business Times· 20 hours agoMadison-based Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 7 days agoMerck MRK will discontinue the Keytruda plus vibostolimab co-formulation arm of a phase III melanoma...
Two local RNA-focused biotechs merge, plan to go public 'at some point' - Boston Business Journal
The Business Journals· 4 hours agoMunshi has experience running larger public companies, having previously led Arena Pharmaceuticals...